The cocktail of drugs given to HIV patients has been dominated by Gilead Sciences (GILD) for over a decade.  They are the undisputed leader with a strong majority of the global market share and 11 HIV drugs which include names you have heard on prime time TV commercials like Biktarvy®, Descovy®, and Truvada®. Gilead had… Continue reading Enzolytics (ENZC) Takes on HIV Heavyweight Gilead Sciences

U.S. biotech stocks are off to a strong start this week. It didn’t take long for investors to get over the Fed’s forecast for interest rate hikes by 2023 which rattled the markets late last week. Concerns of inflation and sooner than expected rate increases have largely subsided allowing the major averages to climb higher.… Continue reading 4 Biotech Stocks to Watch: AMRN AVXL RGBP SBFM

Pfizer (PFE) is approaching COVD-19 with a complete end-to-end solution intent on capturing the lion’s share of the market. It’s no secret that viruses mutate. For the past 90 years, mankind has been using a vaccine to battle the most famous virus of them all called influenza. Vaccines have been able to eliminate polio, tetanus,… Continue reading Todos Medical (TOMDF) with a $22 Million Market Cap Taking on Pharma Giant Pfizer for COVID-19 Antiviral